1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

KCI

Anonymous board for KCI

Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    7
    Views:
    4,197
  2. anonymous
    Replies:
    3
    Views:
    1,593
  3. anonymous
    Replies:
    4
    Views:
    1,536
  4. Anonymous
    Replies:
    102
    Views:
    21,153
  5. anonymous
    Replies:
    4
    Views:
    1,170
  6. anonymous
    Replies:
    16
    Views:
    2,280
  7. anonymous
    Replies:
    58
    Views:
    5,401
  8. anonymous
    Replies:
    19
    Views:
    3,568
  9. anonymous
    Replies:
    3
    Views:
    1,481
  10. anonymous
    Replies:
    5
    Views:
    1,389
  11. anonymous
    Replies:
    7
    Views:
    1,410
  12. anonymous
    Replies:
    14
    Views:
    2,161
  13. anonymous
    Replies:
    39
    Views:
    4,376
  14. anonymous
    Replies:
    24
    Views:
    4,047
  15. anonymous
    Replies:
    3
    Views:
    889
  16. Anonymous
    Replies:
    16
    Views:
    6,322
  17. anonymous
    Replies:
    18
    Views:
    4,206
  18. anonymous
    Replies:
    4
    Views:
    866
  19. anonymous
    Replies:
    3
    Views:
    873
  20. anonymous
    Replies:
    2
    Views:
    629

Thread Display Options

Loading...